LYELL IMMUNOPHARMA IN
0.9205
27-11月-24 16:45:00
15 分の遅延
株式
-0.0032
-0.35%
本日の幅
0.9200 - 0.9969
ISIN
N/A
ソース
NASDAQ
-
Lyell Immunopharma Reports Second Quarter Financial Results and Business Highlights
04 8 2022 16:05:03 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Goldman Sachs Global Healthcare Conference
07 6 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights
10 5 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
04 5 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
29 3 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
08 3 2022 16:45:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Appoints Gary Lee, Ph.D. as Chief Scientific Officer
31 1 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
24 1 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in 40th Annual J.P. Morgan Healthcare Conference
04 1 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
16 12 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
15 12 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Return of Dr. Rick Klausner as Board Chair
02 12 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights
12 11 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Morgan Stanley Global Healthcare Conference
08 9 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
12 8 2021 16:05:02 提供 Nasdaq GlobeNewswire